Insmed
INSM
206 hedge funds and large institutions have $3.58B invested in Insmed in 2020 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 60 increasing their positions, 83 reducing their positions, and 24 closing their positions.
98% more call options, than puts
Call options by funds: $6.65M | Put options by funds: $3.35M
33% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 24
3% more funds holding
Funds holding: 200 → 206 (+6)
2% more capital invested
Capital invested by funds: $3.5B → $3.58B (+$83.6M)
1.63% less ownership
Funds ownership: 107.24% → 105.61% (-1.6%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
28% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 83
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
+$48.1M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$36M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$29M |
| 4 |
SC
Samlyn Capital
New York
|
+$25.2M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$114M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$35.4M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$32.7M |
| 4 |
D.E. Shaw & Co
New York
|
-$22.4M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$15.6M |
INSM Hedge Fund Activity: Q4 2020 in Review
206 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q4 2020, worth a combined $3.58B — up 2.4% from $3.5B a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new INSM positions and 24 closed out — a net gain of 8 holders — while 60 added to existing stakes and 83 trimmed.
The largest buyer was William Blair Investment Management, adding an estimated $48.1M. The largest seller was Fidelity Investments, cutting an estimated $114M.
- 206 institutional investors held Insmed (INSM) as of Q4 2020, up from 200 in Q3 2020.
- Funds reported $3.58B of Insmed stock for Q4 2020, up 2.4% quarter-over-quarter.
- 32 funds opened new Insmed positions in Q4 2020 and 24 closed out, a net change of +8 holders.
- The largest Insmed buyer in Q4 2020 was William Blair Investment Management, an estimated $48.1M added.
- The largest Insmed seller in Q4 2020 was Fidelity Investments, an estimated $114M sold.
Based on aggregated 13F filings for Q4 2020.